Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 10, 2023, titled "Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg".
Press Release Jun 10 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jun 09 2023
- Press Release Jun 08 2023
- Press Release Jun 07 2023
- Press Release May 18 2023
- Press Release May 17 2023
Later from Zydus Lifesciences
- Press Release Jun 13 2023
- Press Release Jun 19 2023
- Press Release Jun 28 2023
- Press Release Jul 03 2023
- Press Release Jul 04 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences